Litcius/Paper detail

Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study

Youcai Li, Xinqing Lin, Yi Li, Jie Lv, Peng Hou, Shaoyu Liu, Penghao Chen, Min Wang, Chengzhi Zhou, Xinlu Wang

2021Molecular Imaging and Biology49 citationsDOI

Topics & Concepts

MedicineNuclear medicineFibroblast activation protein, alphaLymphAdenocarcinomaLungPositron emission tomographyLung cancerLymph nodePathologyCancerInternal medicinePeptidase Inhibition and AnalysisCardiac Structural Anomalies and RepairRadiopharmaceutical Chemistry and Applications
Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study | Litcius